Portal Hypertension Completed Phase 4 Trials for Terlipressin (DB02638)
Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions
Indication | Status | Phase |
---|---|---|
DBCOND0029015 (Portal Hypertension) | Completed | 4 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00369694 | Short Course Terlipressin for Control of Acute Variceal Bleeding | Treatment | |
NCT00534677 | The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed | Treatment |